glp-1 receptor agonists effects on cardiovascular risk reduction Glucagon-like peptide-1 agonist in myocardial infarction and atherosclerotic disease reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety | Cardiovascular Diabetology Cardiovascular and mortality outcomes with

Book online or call for an exact, self-pay quote before your appointment

Besides improving glucose control, reducing body weight, and lowering arterial blood pressure (surrogate endpoints), the breakthroughs were the demonstration of a significant reduction in cardiovascular and renal events in patients with type 2 diabetes at high risk

Supporting Heart Health and Overall Wellness Maintaining good cardiovascular health is essential for anyone beginning a weight loss program

The healing slowdown that accompanies aging relates partly to declining growth hormone levels, reduced blood flow, and less efficient inflammatory responses

I've noticed a positive difference in how I feel day to day